Search Results

ECRI, a global independent healthcare and patient safety nonprofit, names Clinica Imbanaco the winner of its 2024 Health Technology Excellence Award.

ECRI, the nation’s largest independent patient safety organization, has been awarded a $80,000 grant from The AAMI Foundation to investigate the significance of isolation gown barrier penetration and identify ways to improve the protective features for healthcare workers and patients.

DermTech, Inc. announced that ECRI completed its evaluation of the Pigmented Lesion Assay, the foundational assay for the DermTech Melanoma Test, and changed its rating from ‘Inconclusive’ to ‘Somewhat Favorable’.

Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.

ECRI, an independent, nonprofit health services organization that provides technology solutions and evidence-based guidance to healthcare decision makers worldwide, announces the winners of its eleventh annual Healthcare Supply Chain Excellence Award.

Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.

Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.

PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.

The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.